Literature DB >> 16971151

Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations.

M B Coulter-Mackie1, Q Lian.   

Abstract

Alanine:glyoxylate aminotransferase (AGT) is a liver peroxisomal enzyme, deficiency of which results in primary hyperoxaluria type 1 (PH1). More than 65 PH1-related mutations are now documented in the AGT gene (AGXT), of which about 50% are missense. We have generated a spectrum of 15 missense changes including the most common PH1 mutation, G170R, and expressed them on the appropriate background of the major or minor allele, in an Escherichia coli overexpression system and in a rabbit reticulocyte transcription/translation system. We have investigated their effects on enzyme activity, dimerization, aggregation, and turnover. The effect of pyridoxal phosphate (PLP) on dimerization and stability was also investigated. Although all 15 mutant AGTs were expressed as intact proteins in E. coli, only three: G41R and G41V on the major allele, and the common mutation G170R, resulted in significant amounts of enzymatic activity. Dimerization failure was a frequent observation (13/15) except for G41V and D183N. Dimerization was poor with S187F but was substantially improved with PLP. Proteasome-mediated protein degradation was observed for all the mutations except G41R on the major allele, G41V, D183N, G170R, and S218L. Increases in the stability of the mutant enzymes in the presence of PLP were small; however, G41R on the minor allele showed a direct relationship between its half life and the concentration of PLP. The minor allele AGT product and many of the mutants were subject to a limited non-proteasomal proteolytic cleavage when ATP was depleted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971151     DOI: 10.1016/j.ymgme.2006.07.013

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  15 in total

1.  Cystathionine beta-synthase mutants exhibit changes in protein unfolding: conformational analysis of misfolded variants in crude cell extracts.

Authors:  Aleš Hnízda; Vojtěch Jurga; Kateřina Raková; Viktor Kožich
Journal:  J Inherit Metab Dis       Date:  2011-11-09       Impact factor: 4.982

2.  Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.

Authors:  Heike Hoyer-Kuhn; Sina Kohbrok; Ruth Volland; Jeremy Franklin; Barbara Hero; Bodo B Beck; Bernd Hoppe
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-02       Impact factor: 8.237

3.  Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I.

Authors:  Barbara Cellini; Riccardo Montioli; Alessandro Paiardini; Antonio Lorenzetto; Fabio Maset; Tiziana Bellini; Elisa Oppici; Carla Borri Voltattorni
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

4.  Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.

Authors:  Sonia Fargue; Jackie Lewin; Gill Rumsby; Christopher J Danpure
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

5.  Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.

Authors:  Thomas J McCorvie; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2013-04-11

6.  In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase.

Authors:  Erin D Hopper; Adrianne M C Pittman; Michael C Fitzgerald; Chandra L Tucker
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

7.  Rapid profiling of disease alleles using a tunable reporter of protein misfolding.

Authors:  Adrianne M C Pittman; Melissa D Lage; Vladimir Poltoratsky; Justin D Vrana; Alessandro Paiardini; Alessandro Roncador; Barbara Cellini; Robert M Hughes; Chandra L Tucker
Journal:  Genetics       Date:  2012-08-24       Impact factor: 4.562

8.  Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.

Authors:  Elisa Oppici; Riccardo Montioli; Antonio Lorenzetto; Silvia Bianconi; Carla Borri Voltattorni; Barbara Cellini
Journal:  Mol Genet Metab       Date:  2011-10-05       Impact factor: 4.797

Review 9.  Protein homeostasis defects of alanine-glyoxylate aminotransferase: new therapeutic strategies in primary hyperoxaluria type I.

Authors:  Angel L Pey; Armando Albert; Eduardo Salido
Journal:  Biomed Res Int       Date:  2013-07-16       Impact factor: 3.411

10.  The role of protein denaturation energetics and molecular chaperones in the aggregation and mistargeting of mutants causing primary hyperoxaluria type I.

Authors:  Noel Mesa-Torres; Israel Fabelo-Rosa; Debora Riverol; Cristina Yunta; Armando Albert; Eduardo Salido; Angel L Pey
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.